Literature DB >> 28496680

Anticoagulation after Atrial Fibrillation Ablation: Many Blanks to Fill.

Martin Fiala1.   

Abstract

Long-term maintenance of sinus rhythm (SR) after catheter ablation of atrial fibrillation (AF) has remained an open issue awaiting further relevant data. It is of paramount importance as our everyday decisions on discontinuing anticoagulation after ablation rest on the belief in the absence of clinically significant asymptomatic AF episodes and constant SR for the rest of the patient's life. Both aspects are difficult to ascertain, for the tools of truly continuous ECG monitoring are not comfortably applicable, and routine follow-up tends to thin out beyond 1 year in asymptomatic patients without apparent arrhythmia recurrences.

Entities:  

Year:  2010        PMID： 28496680      PMCID： PMC5398822          DOI： 10.4022/jafib.335

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  10 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Long-term outcome after successful catheter ablation of atrial fibrillation.

Authors:  Wendy S Tzou; Francis E Marchlinski; Erica S Zado; David Lin; Sanjay Dixit; David J Callans; Joshua M Cooper; Rupa Bala; Fermin Garcia; Mathew D Hutchinson; Michael P Riley; Ralph Verdino; Edward P Gerstenfeld
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-03-24

3.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

4.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

5.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

6.  Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation.

Authors:  Koonlawee Nademanee; Mark C Schwab; Erol M Kosar; Margaret Karwecki; Michael D Moran; Nithi Visessook; Anthony Don Michael; Tachapong Ngarmukos
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

7.  Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint.

Authors:  Mark D O'Neill; Matthew Wright; Sébastien Knecht; Pierre Jaïs; Mélèze Hocini; Yoshihide Takahashi; Anders Jönsson; Frédéric Sacher; Seiichiro Matsuo; Kang Teng Lim; Leonardo Arantes; Nicolas Derval; Nicholas Lellouche; Isabelle Nault; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  Eur Heart J       Date:  2009-03-08       Impact factor: 29.983

8.  Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation.

Authors:  Martin Fiala; Jan Chovancík; Renáta Nevralová; Radek Neuwirth; Otakar Jiravský; Jaroslav Januska; Marian Branny
Journal:  Pacing Clin Electrophysiol       Date:  2008-08       Impact factor: 1.976

9.  Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties.

Authors:  Yoshihide Takahashi; Mark D O'Neill; Méléze Hocini; Patricia Reant; Anders Jonsson; Pierre Jaïs; Prashanthan Sanders; Thomas Rostock; Martin Rotter; Frédéric Sacher; Stephane Laffite; Raymond Roudaut; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Am Coll Cardiol       Date:  2007-03-09       Impact factor: 24.094

10.  Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach.

Authors:  Thomas Rostock; Daniel Steven; Boris Hoffmann; Helge Servatius; Imke Drewitz; Karsten Sydow; Kai Müllerleile; Rodolfo Ventura; Karl Wegscheider; Thomas Meinertz; Stephan Willems
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.